474 filings
Page 9 of 24
8-K
dme879ac6 q95c4
9 Aug 21
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
4:11pm
8-K
5j2nuwsrm9 uswu8mp
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:06pm
8-K
6j0j0vt3g01l
3 Jun 21
Regulation FD Disclosure
12:00am
4
alg7zm
13 May 21
ANAPTYSBIO / Hamza Suria ownership change
4:50pm
SC 13D/A
1hx1i7uc9yxh8
11 May 21
ANAPTYSBIO / EcoR1 Capital ownership change
4:08pm
4
o14 i8vyy
4 May 21
ANAPTYSBIO / OLEG NODELMAN ownership change
4:51pm
8-K
jcqeusme3
4 May 21
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
4:14pm
4
ezw6zx09p0py q4
27 Apr 21
ANAPTYSBIO / OLEG NODELMAN ownership change
6:23pm
DEFA14A
z4toc2ssgwvzos5xrass
26 Apr 21
Additional proxy soliciting materials
4:02pm
SC 13D/A
e0cym5pybyvczi5e9 1u
13 Apr 21
ANAPTYSBIO / EcoR1 Capital ownership change
12:00am
3
3qezpf irkhr2jzj9
12 Apr 21
ANAPTYSBIO / OLEG NODELMAN ownership change
4:20pm
8-K
sjrg68o74hc3vg0 rd
12 Apr 21
Departure of Directors or Certain Officers
4:05pm
4
o7g97yu4d3tur687ete9
10 Mar 21
Change in insider ownership
5:53pm
SC 13D
88fy9e afu
10 Mar 21
ANAPTYSBIO / EcoR1 Capital ownership change
5:17pm
SC 13D
tq2a 86226hpgz
10 Mar 21
ANAPTYSBIO / EcoR1 Capital Fund ownership change
5:02pm
8-K
v8yol3cb7kp2k9z da
8 Mar 21
AnaptysBio Reports Imsidolimab POPLAR Phase 2 Clinical Trial in Moderate-to-Severe Palmoplantar Pustulosis (PPP) Did Not Meet
8:05am
4
cgb0dxg0el x382fs
25 Feb 21
Change in insider ownership
5:58pm
S-8
r8cqur
25 Feb 21
Registration of securities for employees
4:12pm